US2022133288A1PendingUtilityA1
Micrograft for the treatment of intracranial aneurysms and method for use
Est. expiryJan 20, 2035(~8.5 yrs left)· nominal 20-yr term from priority
A61B 17/12172A61B 2017/00898A61F 2/07A61F 2/06A61B 17/12145A61B 2017/0053B29D 23/18A61B 2090/3966B29K 2067/003A61B 17/1215A61B 2017/00867A61B 17/12118A61B 17/12177A61B 2017/12054B29D 23/00B29K 2105/25A61B 17/1214A61F 2002/077A61B 17/12154A61B 2017/00526A61B 2017/00942A61B 17/0057B29K 2105/0035A61B 2090/0807A61B 2017/00893A61B 17/12031A61B 2017/1205A61B 17/12113A61B 2017/00778A61F 2/95
80
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A device for occluding a vasculature of a patient including a micrograft having an absorbent polymeric structure with a lumen of transporting blood. The micrograft has a series of peaks and valleys formed by crimping. The occluding device is sufficiently small and flexible to be tracked on a guidewire and/or pushed through a microcatheter to a site within the vasculature of the patient. Delivery systems for delivering the micrografts are also disclosed.
Claims
exact text as granted — not AI-modified1 - 20 . (canceled)
21 . A method of treating an intracranial aneurysm comprising the steps of:
a) providing a polymeric occluding device having a lumen therein; b) providing a delivery member supporting the occluding device; c) inserting the delivery member with the occluding device into the intracranial aneurysm, the delivery member retaining the occluding device during delivery of the occluding device to the intracranial aneurysm; d) leaving the occluding device in the intracranial aneurysm; and e) delivering a blocking device into a vessel outside the intracranial aneurysm, the blocking device blocking exit of the occluding device from the intracranial aneurysm.
22 . The method of claim 21 , further comprising the step of manipulating the delivery member to maneuver the occluding device within the intracranial aneurysm.
23 . The method of claim 21 , wherein the occluding device has a permeable structure and blood enters the occluding device through a distal end of the lumen and through spaces in the permeable structure whereby the occluding device becomes saturated with blood and induces blood stagnation.
24 . The method of claim 23 , wherein the occluding device has a preset curved shape and is delivered in a substantially linear configuration and moves to the curved shape when placed within the intracranial aneurysm.
25 . The method of claim 21 , wherein the delivery member extends in a space between the blocking device and a wall of the vessel.
26 . The system of claim 21 , wherein the blocking device is positioned on a delivery member proximal of the occluding device.
27 . The system of claim 21 , wherein the delivery member extends through openings in the occluding device when the blocking device is in the vessel.Join the waitlist — get patent alerts
Track US2022133288A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.